August 6, 2025

CMS Releases Multiple FY 2026 Payment Updates: Key Takeaways for Providers 

Yesterday, the Centers for Medicare & Medicaid Services released several final rules and updates impacting payment and quality expectations for FY 2026. Below is a summary of each announcement and its likely effect on providers across care settings. 


Quarterly Listing of CMS Program Issuances (April–June 2025) 

This listing compiles all CMS transmittals, memoranda, manual updates, and other instructions issued in the second quarter of 2025. While not tied to a specific payment update, it sets the compliance and operational agenda that contractors and providers need to follow going into the next fiscal year. 

Impact: Compliance leaders and revenue cycle teams should review the quarterly listing closely to ensure internal processes reflect the latest guidance on claims processing, provider enrollment, coverage determinations, and survey protocols. 

 

Announcement available at: https://www.federalregister.gov/documents/2025/08/05/2025-14822/medicare-and-medicaid-programs-quarterly-listing-of-program-issuances-april-through-june-2025 


 

FY 2026 Hospice Wage Index and Payment Rate Update + Hospice Quality Reporting Program (HQRP) Changes 

CMS finalized a payment rate increase for hospices along with routine wage index updates. Revisions to HQRP continue the move toward outcome-oriented quality measurement, including preparation for the upcoming HOPE assessment tool. 

 

Impact: Hospices should expect modest payment growth coupled with expanded quality reporting expectations that will require stronger documentation and care coordination practices. 


Announcement available at: https://www.federalregister.gov/documents/2025/08/05/2025-14782/medicare-program-fy-2026-hospice-wage-index-and-payment-rate-update-and-hospice-quality-reporting 


 

FY 2026 Inpatient Psychiatric Facility (IPF) PPS Final Rule 

This rule updates the IPF per diem base rate, wage index, and labor share for FY 2026. CMS also modifies several measures in the IPF Quality Reporting Program to put greater emphasis on behavioral health outcomes and performance improvement. 

 

Impact: Psychiatric hospitals and units will see a net payment increase, but must be ready to support enhanced quality tracking and accurate measure reporting to avoid penalties. 


Announcement available at: https://www.federalregister.gov/documents/2025/08/05/2025-14781/medicare-program-fy-2026-inpatient-psychiatric-facilities-prospective-payment-system-rate-update 


 

FY 2026 Inpatient Rehabilitation Facility (IRF) PPS Final Rule 

IRFs will receive a payment increase in FY 2026 tied to market basket and wage index changes. CMS also continues to strengthen the IRF Quality Reporting Program by refining functional outcome measures and signaling future alignment with post-acute value initiatives. 

 

Impact: IRFs should prepare for higher reimbursement alongside increased accountability for quality outcomes and performance on patient assessment data. 


Announcement available at: https://www.federalregister.gov/documents/2025/08/05/2025-14780/medicare-program-inpatient-rehabilitation-facility-prospective-payment-system-for-federal-fiscal  


 

Bottom Line for Providers 

CMS continues its trend of linking payment updates to quality, transparency, and data integrity. While most settings will enjoy FY 2026 reimbursement increases, each sector should be bracing for greater reporting rigor and operational alignment with value-based objectives. 


To stay ahead, providers should prioritize internal assessments of their current documentation, coding, and quality reporting workflows to identify any vulnerabilities, considering the new requirements. Investment in education, technology, and cross-functional collaboration will be essential to safeguard compliance, protect revenue, and successfully navigate the evolving value-based landscape. 

MRI brain scans illustrating symptoms of PRES with title text overlay.
December 9, 2025
Learn the symptoms of PRES, key treatment considerations, ICD-10-CM code I67.83, and documentation tips for CDI and accurate DRG assignment.
Microscopic immune cells interacting in cellular environment, illustrating immune effector activity
By Katie Curry December 1, 2025
Understand ICANS documentation and ICD-10 coding with guidance on the ICANS grading system, ICE score, clinical indicators, and CAR T-cell neurotoxicity.
Fingerstick blood glucose test being performed, illustrating screening and monitoring practices for gestational diabetes.
By Katie Curry November 3, 2025
Gestational Diabetes
Clinician pointing to anatomical kidney model illustrating acute kidney injury.
By Katie Curry October 20, 2025
Learn how to identify, document, and code acute kidney injury (AKI), including diagnostic criteria, staging, ICD-10-CM guidance, and CDI query considerations.
Blurred hospital scene symbolizing CDI review of firearm injury intent reporting.
By Katie Curry September 30, 2025
Learn how firearm injury intent is documented and reported in ICD-10-CM, including intent categories, external cause codes, and documentation considerations.
Title image for the ventricular standstill clinical documentation and coding overview
By Katie Curry September 22, 2025
Learn how ventricular standstill is documented and coded, including clinical indicators, ICD-10-CM guidance, and common documentation considerations.
Title image for neurostorming (PSH) documentation and coding
By Katie Curry September 7, 2025
Learn how neurostorming, also known as paroxysmal sympathetic hyperactivity (PSH), is documented and coded using ICD-10-CM guidance.
Title photo of doctor for New ICD-10-CM code E11.A for type 2 diabetes mellitus in remission
By Katie Curry August 7, 2025
FY 2026 ICD-10-CM coding guidance for new code E11.A, Type 2 diabetes mellitus without complications in remission, including documentation and query considerations.
By Katie Curry July 9, 2025
Definition: Neonatal encephalopathy (NE) is a clinically defined syndrome of disturbed neurologic function in the earliest days of life in a term or late preterm infant, manifested by difficulty with initiating and maintaining respiration, depression of tone and reflexes, subnormal level of consciousness, and often seizures. Clinical presentation: Low APGAR scores and/or weak/absent cry in the delivery room. Hyperalert, irritable, lethargic, obtunded. Decreased spontaneous movements, poor tone, blunted or absent primitive reflexes, seizure activity. Breathing and/or feeding difficulties. Documentation Tips: The CDS should review to identify the underlying etiology . (e.g., hypoxic-ischemic event, infection, metabolic disorder). Review clinical indicators that may indicate associated conditions , such as seizures, abnormal imaging, acidosis, or multi-organ dysfunction. Review the documentation for the timing of onset (e.g., at birth, delayed). Common clinical indicators include low APGAR scores, need for resuscitation, abnormal tone, or altered level of consciousness.  ICD-10-CM Coding: P91.811, Neonatal encephalopathy in diseases classified elsewhere P91.819, Neonatal encephalopathy, unspecified Use when the type or etiology of NE is not documented Query Example: To the Attending Neonatologist: Documentation in the medical record indicates the newborn infant delivered from mother with placental abruption demonstrates seizures, abnormal muscle tone, low APGAR scores, and required resuscitation at birth. Imaging showed evidence of cerebral edema. The diagnosis of “neonatal encephalopathy” was documented in the assessment. Query: Based on the clinical indicators, can you clarify the type and cause of the encephalopathy in this newborn? Please select the most appropriate option below or specify another diagnosis: Neonatal encephalopathy due to Hypoxic-ischemic encephalopathy (HIE) Neonatal encephalopathy due to other etiology (please specify) Other (please specify): __________
By Katie Curry May 12, 2025
Definition: Tumor lysis syndrome (TLS) is an oncologic emergency caused by massive tumor cell lysis and the release of large amounts of potassium, phosphate, and uric acid into the systemic circulation. Deposition of uric acid and/or calcium phosphate crystals in the renal tubules can result in acute kidney injury.
Show More